News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Astellas Pharma Inc. (YPH.BE), GlaxoSmithKline (GSK) Vie to Make "High Altitude" Anemia Pill


4/19/2013 10:53:24 AM

Japan's Astellas Pharma and Britain's GlaxoSmithKline are competing to develop a new kind of medicine that boosts production of red blood cells by making the body think it is at high altitude. Their experimental drugs - both given as pills - could create a major new market in treating anemia and other serious conditions, including circulatory problems and wound damage. They may also attract unscrupulous athletes seeking a handy oral alternative to injections of EPO, or erythropoietin, the blood enhancer that has become a byword for doping in cases involving cyclist Lance Armstrong and others.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES